Education
About Us
Working with TipRanks
Follow Us
aTyr Pharma (ATYR)
NASDAQ:ATYR
Total Valuation
aTyr Pharma has a market cap or net worth of $454.81M. The enterprise value is $50.72M.
Market Cap$454.81M
Enterprise Value$50.72M
Share Statistics
aTyr Pharma has 89,004,430 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding89,004,430
Owned by Insiders1.56%
Owned by Institutions21.87%
Financial Efficiency
aTyr Pharma’s return on equity (ROE) is -0.91 and return on invested capital (ROIC) is -81.71%.
Return on Equity (ROE)-0.91
Return on Assets (ROA)-0.66
Return on Invested Capital (ROIC)-81.71%
Return on Capital Employed (ROCE)-0.83
Revenue Per Employee4.20K
Profits Per Employee-1.14M
Employee Count56
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of aTyr Pharma is -4.20. aTyr Pharma’s PEG ratio is 0.11.
PE Ratio-4.20
PS Ratio0.00
PB Ratio0.69
Price to Fair Value3.84
Price to FCF-1.13
Price to Operating Cash Flow-1.17
PEG Ratio0.11
Income Statement
In the last 12 months, aTyr Pharma had revenue of 235.00K and earned -64.02M in profits. Earnings per share was -0.86.
Revenue235.00K
Gross Profit-1.30M
Operating Income-67.91M
Pretax Income-64.02M
Net Income-64.02M
EBITDA-66.37M
Earnings Per Share (EPS)-0.86
Cash Flow
In the last 12 months, operating cash flow was -62.16M and capital expenditures -48.00K, giving a free cash flow of -62.21M billion.
Operating Cash Flow-62.16M
Free Cash Flow-62.21M
Free Cash Flow per Share-0.70
Dividends & Yields
aTyr Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.16
52-Week Price Change222.44%
50-Day Moving Average4.15
200-Day Moving Average3.39
Relative Strength Index (RSI)54.09
Average Volume (3m)2.34M
Important Dates
aTyr Pharma upcoming earnings date is Aug 13, 2025, After Close (Confirmed).
Last Earnings DateMay 7, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend Date―
Financial Position
aTyr Pharma as a current ratio of 5.48, with Debt / Equity ratio of 16.14%
Current Ratio5.48
Quick Ratio5.48
Debt to Market Cap0.00
Net Debt to EBITDA-0.03
Interest Coverage Ratio0.00
Taxes
In the past 12 months, aTyr Pharma has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
aTyr Pharma EV to EBITDA ratio is -4.08, with an EV/FCF ratio of -3.92.
EV to Sales1.15K
EV to EBITDA-4.08
EV to Free Cash Flow-3.92
EV to Operating Cash Flow-3.92
Balance Sheet
aTyr Pharma has $76.35M in cash and marketable securities with $12.99M in debt, giving a net cash position of -$63.36M billion.
Cash & Marketable Securities$76.35M
Total Debt$12.99M
Net Cash-$63.36M
Net Cash Per Share-$0.71
Tangible Book Value Per Share$0.94
Margins
Gross margin is 83.68%, with operating margin of -28899.57%, and net profit margin of -27243.83%.
Gross Margin83.68%
Operating Margin-28899.57%
Pretax Margin-27243.40%
Net Profit Margin-27243.83%
EBITDA Margin-28244.26%
EBIT Margin-28899.57%
Analyst Forecast
The average price target for aTyr Pharma is $22.33, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$22.33
Price Target Upside343.94% Upside
Analyst ConsensusStrong Buy
Analyst Count7
Revenue Growth Forecast-100.00%
EPS Growth Forecast10.73%